Serum LOX-1 is a novel prognostic biomarker of colorectal cancer

Nakashima-Nakasuga, C; Hazama, S; Suzuki, N; Nakagami, Y; Xu, M; Yoshida, S; Tomochika, S; Fujiwara, N; Matsukuma, S; Matsui, H; Tokumitsu, Y; Kanekiyo, S; Shindo, Y; Maeda, N; Tsunedomi, R; Iida, M; Takeda, S; Yoshino, S; Ueno, T; Hamamoto, Y; Ogihara, H; Hoshii, Y; Nagano, H

Nagano, H (corresponding author), Yamaguchi Univ, Dept Gastroenterol Breast & Endocrine Surg, Grad Sch Med, 1-1-1 Minami Kogushi, Ube, Yamaguchi 7558505, Japan.

INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2020; 25 (7): 1308

Abstract

Background Colorectal cancer is the third most common cancer worldwide. If biomarkers can be identified in liquid biopsy, diagnosis and treatment can ......

Full Text Link